In recent trading session, Transmedics Group Inc (NASDAQ:TMDX) saw 0.61 million shares changing hands at last check today with its beta currently measuring 1.99. Company’s recent per share price level of $155.46 trading at $10.9 or 7.54% at last check today assigns it a market valuation of $5.19B. That most recent trading price of TMDX’s stock is at a discount of -14.09% from its 52-week high price of $177.37 and is indicating a premium of 76.57% from its 52-week low price of $36.42. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.91 million shares which gives us an average trading volume of 814.32K if we extend that period to 3-months.
For Transmedics Group Inc (TMDX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.40. Splitting up the data highlights that, out of 7 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.29 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Transmedics Group Inc (NASDAQ:TMDX) trade information
Upright in the green today for gaining 7.54%, in the last five days TMDX remained trading in the red while hitting it’s week-highest on Monday, 09/23/24 when the stock touched $155.46 price level, adding 6.6% to its value on the day. Transmedics Group Inc’s shares saw a change of 96.96% in year-to-date performance and have moved -5.78% in past 5-day. Transmedics Group Inc (NASDAQ:TMDX) showed a performance of -8.01% in past 30-days. Number of shares sold short was 5.5 million shares which calculate 6.88 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 174.5 to the stock, which implies a rise of 10.91% to its recent value today. Analysts have been projecting 45 as a low price target for the stock while placing it at a high target of 208. It follows that stock’s current price would jump 71.05% in reaching the projected high whereas dropping to the targeted low would mean a gain of 71.05% for stock’s current value.
Transmedics Group Inc (TMDX) estimates and forecasts
Statistics highlight that Transmedics Group Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 110.26% of value to its shares in past 6 months, showing an annual growth rate of 259.74% while that of industry is 13.20. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 83.90% from the last financial year’s standing.
9 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 115M for the same. And 9 analysts are in estimates of company making revenue of 119.37M in the next quarter. Company posted 66.43M and 81.17M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 8.36% during past 5 years.
Transmedics Group Inc (NASDAQ:TMDX)’s Major holders
Insiders are in possession of 3.20% of company’s total shares while institution are holding 104.91 percent of that, with stock having share float percentage of 108.37%. Investors also watch the number of corporate investors in a company very closely, which is 104.91% institutions for Transmedics Group Inc that are currently holding shares of the company. FMR LLC is the top institutional holder at TMDX for having 4.49 million shares of worth $676.31 million. And as of 2024-06-30, it was holding 13.7063 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 2.65 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.0755 of outstanding shares, having a total worth of $398.47 million.
On the other hand, Vanguard Total Stock Market Index Fund and Mutual Fund Ser Tr-Eventide Gilead Fund are the top two Mutual Funds which own company’s shares. As of Jun 30, 2024, the former fund manager was holding 984.79 shares of worth $154.24 million or 2.95% of the total outstanding shares. The later fund manager was in possession of 898.06 shares on Jun 30, 2024, making its stake of worth around $140.66 million in the company or a holder of 2.69% of company’s stock.
